Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
China licenses more drugs to other countries than it licenses from them, and it has surpassed the United States in its number of clinical trials.
Simplified Text
China licenses more drugs to other countries than it licenses from them and has surpassed the United States in its number of clinical trials.
Confidence Score
0.950
Claim Maker
Steven Rattner
Context Type
Opinion Essay
Context Details
{
    "date": "February 10, 2026",
    "topic": "China's economic and technological advancements",
    "author": "Steven Rattner"
}
Subject Tags
China Pharmaceuticals Health
UUID
a11635bf-7b80-4c4f-8adb-6cb50f9a6c98
Vector Index
âś— No vector
Created
February 15, 2026 at 3:00 PM (6 months ago)
Last Updated
February 15, 2026 at 3:00 PM (6 months ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/02/10/opinion/china-ai-ev-trump.html
I Just Returned From China. We Are Not Winning.
Completed Opinion
26 claims 🔥
1 week ago
https://nytimes.com/2026/02/10/opinion/china-ai-ev-trump.html

Steven Rattner argues that the US is not winning the economic competition with China, highlighting China's advancements in AI, manufacturing, and drug development. He suggests the US needs to focus on its own economic strengths and rethink industrial policy to compete effectively. The article criticizes Trump's policies and advocates for increased investment in science and technology.

China Economy Trade Artificial Intelligence Manufacturing Industrial Policy United States Trump Administration

Similar Claims (5)

Other claims identified as semantically similar to this one.